pramipexole has been researched along with Refractory Depression in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dionys, V; Sienaert, P | 1 |
| Attenburrow, MJ; Au-Yeung, SK; Bogacz, R; Browning, M; Chan, F; Cipriani, A; Cleare, A; Cowen, P; Edwards, C; Evans, J; Geddes, J; Griffiths, J; Harmer, CJ; Harrison, PJ; Kessler, D; Lewis, G; Rendell, J; Roberts, S; Shanyinde, M; Simon, J; Singh, I; Watson, S; Yu, LM | 1 |
| Betro', S; de Filippis, R; Iommi, M; Tundo, A | 1 |
| Cusin, C; Fava, M; Iosifescu, DV; Iovieno, N; Nierenberg, AA; Perlis, RH; Rush, AJ | 1 |
| Diaz, SH; Dunklee, L; Escalona, R; Fawcett, J; Romo, P; Rush, AJ; Vukelich, J; Yarns, BC | 1 |
| Escalona, R; Fawcett, J | 1 |
1 review(s) available for pramipexole and Refractory Depression
| Article | Year |
|---|---|
[Pramipexole in bipolar depression: a literature review and clinical recommendations].
Topics: Bipolar Disorder; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Humans; Pramipexole; Retrospective Studies | 2021 |
2 trial(s) available for pramipexole and Refractory Depression
| Article | Year |
|---|---|
PAX-D: study protocol for a randomised placebo-controlled trial evaluating the efficacy and mechanism of pramipexole as add-on treatment for people with treatment resistant depression.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Humans; Pramipexole; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents; Benzothiazoles; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pramipexole; Psychiatric Status Rating Scales; Remission Induction; Treatment Outcome | 2013 |
3 other study(ies) available for pramipexole and Refractory Depression
| Article | Year |
|---|---|
Efficacy and safety of 24-week pramipexole augmentation in patients with treatment resistant depression. A retrospective cohort study.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Brief Psychiatric Rating Scale; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Off-Label Use; Pramipexole; Retrospective Studies; Treatment Outcome | 2022 |
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Benzothiazoles; Bipolar Disorder; Bupropion; Cohort Studies; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dopamine Agonists; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nortriptyline; Pramipexole; Retrospective Studies; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Pramipexole in Treatment Resistant-Depression, Possible Role of Inflammatory Cytokines.
Topics: Anhedonia; Animals; Antidepressive Agents; Benzothiazoles; Cytokines; Depressive Disorder, Treatment-Resistant; Humans; Pramipexole | 2017 |